Charles River Laboratories CRL Impairment charges for facilities consolidation
Impairment charges for facilities consolidation at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's impairment charges for facilities consolidation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's impairment charges for facilities consolidation?
- Charles River Laboratories (CRL) reported impairment charges for facilities consolidation of $15.86M in Q1 2026.
- How has Charles River Laboratories's impairment charges for facilities consolidation changed year-over-year?
- Charles River Laboratories's impairment charges for facilities consolidation increased by 50.0% year-over-year, from $10.58M to $15.86M.
- What is the long-term trend for Charles River Laboratories's impairment charges for facilities consolidation?
- Over 3 years (2021 to 2025), Charles River Laboratories's impairment charges for facilities consolidation has grown at a 607.0% compound annual growth rate (CAGR), from $733K to $259.08M.